Literature DB >> 19034484

Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Martin Hermel1, Jonathan Prenner, Motaz Alabdulrazzak, Wendy Dailey, Michael Hartzer.   

Abstract

PURPOSE: Intravitreal plasmin creates a posterior vitreous detachment, but may also liquefy the vitreous. This study measures the rate of vitreous removal from rabbit eyes after plasmin injection in vivo.
METHODS: Intravitreal injections of 150 IU hyaluronidase (n = 5), 0.5 activity units (AU, n = 6) or 0.9 AU of streptokinase-activated human plasmin (n = four groups of 6) in 0.1 ml were performed in rabbits, the fellow eyes received 0.1 ml BSS. After 30 min (hyaluronidase), 30 min, 4 h, 12 h or 24 h (0.9 AU plasmin) or 24 h (0.5 AU plasmin), 1 ml of vitreous was removed from each eye without infusion, using a 25-gauge cutter and a standardized protocol. Animals were sacrificed after surgery.
RESULTS: Compared to fellow eyes, the average rate of vitreous removal was increased by hyaluronidase by 68.9 +/- 6.3% (p < 0.05) and by 0.5 AU plasmin (24 h) by 26.8 +/- 3.3% (p < 0.05). 0.9 AU of plasmin increased removal rates by 0.8 +/- 10% (n.s.), 15.4 +/- 6.3% (p < 0.05), 40.3 +/- 3.1% (p < 0.05), and 71.9 +/- 32.4% (p < 0.05) after 30 min, 4 h, 12 h and 24 h incubation respectively. The ratios of removal rates of treated/control eyes in the 0.9 AU groups showed a linear correlation with incubation time (r = 0.783, p < 0.0001).
CONCLUSION: Intravitreal plasmin increases the rate of vitreous removal in rabbits.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034484     DOI: 10.1007/s00417-008-1000-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel.

Authors:  P N Bishop; D McLeod; A Reardon
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

2.  Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.

Authors:  J Sebag; Rafat R Ansari; Kwang I Suh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

3.  Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.

Authors:  M Hermel; M Mahgoub; T Youssef; M I Azrak; H Raza; C Alldredge; M Trese; G A Williams; M Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-20       Impact factor: 3.117

4.  Study of vitreous liquifaction by NMR spectroscopy and imaging.

Authors:  J Aguayo; B Glaser; A Mildvan; H M Cheng; R G Gonzalez; T Brady
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

5.  Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin.

Authors:  Flemming Staubach; Veronika Nober; Peter Janknecht
Journal:  Curr Eye Res       Date:  2004 Oct-Nov       Impact factor: 2.424

Review 6.  Enzymatic vitreous surgery.

Authors:  M T Trese
Journal:  Semin Ophthalmol       Date:  2000-06       Impact factor: 1.975

7.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

8.  Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.

Authors:  Martin Hermel; Norbert F Schrage
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

9.  Chemical analysis of bovine and porcine vitreous humors: correlation of normal values with serum chemical values and changes with time and temperature.

Authors:  P S McLaughlin; B G McLaughlin
Journal:  Am J Vet Res       Date:  1987-03       Impact factor: 1.156

Review 10.  MMP-2: expression, activation and inhibition.

Authors:  M L Corcoran; R E Hewitt; D E Kleiner; W G Stetler-Stevenson
Journal:  Enzyme Protein       Date:  1996
View more
  4 in total

1.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

2.  Pharmacologic vitreolysis.

Authors:  Hossein Nazari; Mehdi Modarres-Zadeh; Arash Maleki
Journal:  J Ophthalmic Vis Res       Date:  2010-01

Review 3.  Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.

Authors:  Francisco R Stefanini; Maurício Maia; Paulo Falabella; Marcel Pfister; Moritz Niemeyer; Amir H Kashani; Mark S Humayun; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2014-05-06

Review 4.  Ocriplasmin for vitreoretinal diseases.

Authors:  Irena Tsui; Carolyn K Pan; Ehsan Rahimy; Steven D Schwartz
Journal:  J Biomed Biotechnol       Date:  2012-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.